6.600USD-2.94%Mkt Cap: 48.26M $P/E: —1d ago
DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data anal…
Industry Peers
Health Information Servicesvs Health Information Services
P/B
Cheaper
1M Perf
Higher
$28.83BUSDP/E 31.5
$13.69BUSDP/E 90.6
$10.40BUSD
$7.57BUSDP/E 33.8
$6.42BUSD
$4.87BUSD
$3.94BUSDP/E 30.6
$3.24BUSDP/E 151.4
$2.53BUSD
$1.89BUSDP/E 94.4
$1.53BUSD
$1.30BUSD
$1.21BUSD
$1.02BUSD
$975.39MUSDP/E 48.0
$871.07MUSDP/E Infinity
$796.11MUSDP/E 40.7
$713.43MUSDP/E 33.6
$635.66MUSDP/E 64.3
$609.65MUSD
$563.71MUSDP/E 13.3
$581.50MUSD
$501.65MUSDP/E 28.1
$516.62MUSD
$462.84MUSDP/E 26.3
$486.12MUSDP/E 55.3
$476.60MUSD
$393.13MUSDP/E 90.4
$370.16MUSD
$282.18MUSD
$227.30MUSDP/E 13.9
$213.88MUSDP/E 17.4
$199.74MUSD
$154.92MUSDP/E 30.8
$145.80MUSDP/E 39.3
$152.38MUSD
$147.05MUSD
$134.30MUSDP/E Infinity
$119.30MUSDP/E 26.6
$107.34MUSDP/E 15.9
$90.09MUSDP/E 16.3
$87.68MUSD
$63.42MUSDP/E 11.0
$62.20MUSD
$61.11MUSDP/E 22.1
$48.56MUSDP/E 46.3
$47.87MUSDP/E 57.6
$41.23MUSD
$41.63MUSD
$23.33MUSDP/E 55.8
$23.82MUSDP/E 23.0
$21.92MUSD
$19.31MUSD
$13.45MUSD
$13.16MUSD
$10.93MUSD
$9.67MUSDP/E 14.9
$9.47MUSD
$7.09MUSD
$6.52MUSD
$5.18MUSD
$5.62MUSD
$3.80MUSDP/E Infinity
$3.67MUSDP/E 0.0
$3.46MUSD
$3.38MUSD
$2.99MUSD
$1.44MUSDP/E Infinity
$512.9KUSDP/E 0.0
$373.4KUSD
$165.6KUSD
—
—
EYES
Corgi Data & Surveillance ETF—P/E 30.5
—
CRY
GraniteShares YieldBOOST CRCL ETF—
Indicators:|
Key Statistics
Company
Market Cap48.26M $
Enterprise Value60.07M $
Revenue (TTM)21.19M $
Gross Profit12.66M $
Net Income (TTM)-41.71M $
Revenue/Share4.208 USD
Last Price6.600 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees160
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-9.71
PEG—
EV/EBITDA-1.87
EV/Revenue2.83
P/S2.28
P/B0.77
EPS (TTM)-8.50
EPS (Forward)-0.68
52W Range
5.8456% of range17.74
52W High17.74 USD
52W Low5.845 USD
Profitability
Gross Margin56.64%
Oper. Margin-130.89%
EBITDA Margin-151.71%
Profit Margin-186.56%
ROE-61.41%
ROA-37.90%
Growth
Revenue Growth-17.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-25.94M $
CapEx (TTM)142.00K $
FCF Margin-51.34%
FCF Yield-22.54%
Net Debt11.80M $
Net Debt/EBITDA-0.37
Balance Sheet
Debt/Equity0.47
Current Ratio3.07
Quick Ratio2.57
Book Value/Sh8.546 USD
Cash/Share2.737 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateNov 18, 2019
Splits
Last Split1:20
Split DateAug 28, 2025
Analyst Consensus
Rating—
Target (Mean)18.50 USD
Upside (mean)+180.3%
Target Range10.00 USD – 28.00 USD
$10.00+180.3% to mean$28.00
# Analysts4
Ownership
Shares Out.7.31M
Float5.23M
Insiders21.08%
Institutions12.03%
Short Interest
Short Ratio11.5d
Short % Float1.12%
Short % Out.1.09%
Shares Short79.73K
Short (prev mo.)72.78K
Technical
SMA 507.467 (-11.6%)
SMA 20010.34 (-36.2%)
Beta1.08
S&P 52W Chg20.05%
Avg Vol (30d)8.79K
Avg Vol (10d)13.23K
Technical Indicators
RSI (14)42.1
MACD-0.3155
MACD Signal-0.3044
MACD Hist.-0.0111
BB Upper8.078 USD
BB Middle7.011 USD
BB Lower5.944 USD
BB Width30.45%
ATR (14)0.4797 USD
Vol Ratio (20d)0.57x